ENTrigue Surgical, Inc.

ENTrigue Surgical, Inc. designs, develops, manufactures, and distributes instruments, materials, and medical devices primarily for sinus surgery. It offers Ventera Sinus Dilation System, an alternative to other balloon dilation systems; ENTact Septal Stapler, a systems that supplants the need to suture; Synaero Hemostatic Gel, a surface-acting alternative to nasal packing and space-occupying gel that controls mild to moderate bleeding without expanding; and SerpENT Articulating Instruments, which enable surgeons to reach around corners and perform precise dissection. The company also provides an MediENT Middle Turbinate Implant, a resorbable implant that anchors the middle turbinate to the septum. 

ENTrigue was acquired by Arthrocare (NASD: ARTC) on July 1, 2013 which was subsequently acquired by Smith & Nephew (LSA: SN; NYSE: SNN) on 29 May, 2014.

Ventera® Sinus Dilation Technology